CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 510 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 510 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | -60.0% | 510 | -37.8% | 0.00% | -50.0% |
| Q2 2021 | $5,000 | -16.7% | 820 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +50.0% | 820 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | -20.0% | 820 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | +66.7% | 820 | +182.8% | 0.00% | +100.0% |
| Q4 2019 | $3,000 | – | 290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |